Benzinga

Benzinga

Benzinga

samedi, septembre 05

DarioHealth Corp

DRIONASDAQ
Trade with Public
Trade with Public
$7.24
0.263.72%
À la clôture: Sep 4, 5:00 PM EST
$7.40
0.162.21%
Après les heures: 7:59 PM EST
AperçuActualitésPrévisions de résultatsObjectifs de coursDonnées financièresSentimentActionnariatComparerRapport sur les stocks

DarioHealth Financials

DarioHealth (DRIO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
DarioHealth Q2 Adj. EPS $(0.72) Beats $(1.22) Estimate, Sales $5.177M Miss $5.923M Estimate

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(1.22) by 40.98 percent. This is a 82.44 percent increase over losses of $(4.10) per share from the
Benzinga Newsdesk

Earnings Scheduled For May 13, 2026

Benzinga Insights

PRO
DarioHealth Q1 Adj. EPS $(0.95) Beats $(1.48) Estimate, Sales $5.584M Beat $5.484M Estimate.

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.95) per share which beat the analyst consensus estimate of $(1.48) by 35.81 percent. This is a 60.42 percent increase over losses of $(2.40) per share from the
Benzinga Newsdesk

PRO
DarioHealth Q4 Adj. EPS $(0.82) Up From ($0.80) YoY

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.82) per share, which is a 2.12 percent decrease over losses of $(0.80) per share from the same period last year. 
Benzinga Newsdesk

Earnings Scheduled For March 19, 2026

Benzinga Insights

PRO
DarioHealth Q4 Sales $5.200M Beat $5.047M Estimate, Net loss $6.460M

DarioHealth (NASDAQ:DRIO) reported quarterly sales of $5.200 million which beat the analyst consensus estimate of $5.047 million by 3.03 percent. This is a 31.61 percent decrease over sales of $7.604 million the same
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved